Scotia Capital Inc. Lexaria Bioscience Corp. Transaction History
Scotia Capital Inc.
- $17.9 Billion
- Q4 2024
A detailed history of Scotia Capital Inc. transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Scotia Capital Inc. holds 10,000 shares of LEXX stock, worth $14,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$14,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.47MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY460KShares$667,0000.01% of portfolio
-
Invenomic Capital Management LP Boston, MA411KShares$595,5590.04% of portfolio
-
Geode Capital Management, LLC Boston, MA167KShares$241,6840.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA127KShares$184,7770.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL60.6KShares$87,9280.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $8.63M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...